New Study Points to Longer Duration of Axillary Lymphadenopathy After COVID-19 Vaccine
In sharp contrast to previous reporting of side effects from clinical trials of COVID-19 vaccines, new findings from breast ultrasound research revealed a significantly longer duration of axillary lymphadenopathy among people who had COVID-19 vaccination.1 The retrospective study, which was recently published in the American Journal of Roentgenology, involved 111 …